Prescription Required
Formulation: Nasal spray ampule
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Nasal spray ampule
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Migranal Nasal Spray is a prescription medication used to treat acute migraine attacks, with or without aura.
It contains dihydroergotamine mesylate, an active ingredient that helps relieve migraine headache pain and associated symptoms, such as nausea and sensitivity to light and sound.
Migranal belongs to a class of medications called ergot alkaloids. These medications act on certain serotonin receptors in the nervous system and help regulate blood vessel activity and pain signals involved in migraine attacks.
Migranal works partly by narrowing certain blood vessels and reducing the release of substances that contribute to migraine-related inflammation and pain.
The medication is designed to treat migraine attacks after they begin, rather than prevent future migraines.
Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura.
A migraine is a neurological condition that can cause moderate to severe headache pain, often accompanied by other symptoms.
Migraine headaches may cause throbbing or pulsing pain, usually on one side of the head, although both sides can be affected.
Other common symptoms include nausea, vomiting, and increased sensitivity to light, sound, or certain smells.
Some patients may also experience dizziness, fatigue, or difficulty concentrating.
Migranal helps relieve migraine symptoms by acting on serotonin receptors involved in migraine pain pathways.
These actions help reduce the activity of certain pain-related nerves and substances associated with migraine attacks.
As a result, headache pain and other migraine symptoms may gradually improve.
Migranal is generally used when a migraine attack begins, following the dosing instructions provided by a healthcare provider.
Migranal is intended to treat an existing migraine attack. It should not be used daily to prevent migraines.
Migranal Nasal Spray may be prescribed to treat migraine attacks that occur with aura.
Migraine aura involves temporary neurological symptoms that may develop before or during a migraine headache.
These symptoms are commonly related to changes in nerve activity in the brain.
Visual symptoms are among the most common types of migraine aura.
Some patients may see flashing lights, zigzag patterns, blind spots, or shimmering shapes.
Others may experience tingling, numbness, or temporary difficulty speaking.
Aura symptoms usually develop gradually and often last between five and 60 minutes.
A headache may follow the aura, although some people experience aura without significant headache pain.
Migranal can help treat the headache phase of migraine with aura.
However, it is not specifically intended to eliminate aura symptoms.
Tell your healthcare provider about your aura symptoms before using Migranal, especially if you experience muscle weakness or symptoms that are unusual for you.
Migranal should not be used to treat hemiplegic migraine or migraine with brainstem aura, historically called basilar migraine.
Migranal Nasal Spray is also indicated for migraine attacks that occur without aura.
Migraine without aura is a common type of migraine in which headache pain develops without the temporary neurological warning symptoms associated with aura.
Patients may experience moderate to severe throbbing or pulsing pain.
The pain may become worse during physical activity or routine movements.
Other symptoms may include nausea, vomiting, and sensitivity to light or sound.
Migraine attacks can last several hours or longer if they are not treated.
Migranal helps relieve these attacks by acting on pain pathways and blood vessel receptors involved in migraine.
Using the medication as directed may help reduce headache pain and improve associated symptoms.
However, the response to treatment varies between individuals.
Use Migranal according to your healthcare provider’s instructions when treating migraine attacks without aura.
Cluster headaches are a separate type of severe headache that occurs in repeated attacks.
They often cause intense pain around one eye or on one side of the head.
Other symptoms may include eye redness, tearing, nasal congestion, and restlessness.
Although dihydroergotamine has been studied and sometimes used for cluster headaches in certain clinical settings, Migranal Nasal Spray is not FDA-approved for treating cluster headaches.
Different forms of dihydroergotamine may be considered by headache specialists in selected circumstances.
However, this does not mean that Migranal Nasal Spray is an established or approved treatment for cluster headache attacks.
Cluster headaches often require medications that act quickly, such as high-flow oxygen or certain triptans.
Your healthcare provider can determine which treatment is appropriate based on your diagnosis and medical history.
Do not use Migranal Nasal Spray to treat cluster headaches unless your healthcare provider specifically recommends it.Â
Migranal contains dihydroergotamine, a medication that acts on several receptors involved in blood vessel regulation and migraine pain.
Its effects include activity at certain serotonin receptors, particularly receptors involved in migraine signaling.
These actions help reduce migraine-related pain and inflammation.
By affecting blood vessels and nerve signaling, Migranal can help relieve an ongoing migraine attack.
Unlike preventive migraine medications, Migranal is designed for use during an acute attack.
Migranal Nasal Spray is intended for nasal use only and should be used exactly as prescribed.
It is not intended for daily migraine prevention or for treating every type of headache.
Migranal can cause serious blood circulation problems in certain patients because it can narrow blood vessels.
Tell your healthcare provider if you have heart disease, uncontrolled high blood pressure, circulation problems, or a history of stroke.
Migranal must not be used during pregnancy.
It can also interact dangerously with certain antibiotics, antifungal medications, and other migraine treatments.
Do not use Migranal within 24 hours of taking a triptan or another ergot-type migraine medication.
Contact your healthcare provider if your migraines become more frequent, your symptoms worsen, or treatment does not provide adequate relief.
Migranal should only be used for migraine attacks as directed by your healthcare provider.Â
Migranal Nasal Spray is a prescription medication used to treat acute migraine attacks with or without aura.
It contains dihydroergotamine mesylate, an active ingredient that helps relieve migraine headache pain and associated symptoms, such as nausea and sensitivity to light and sound.
Migranal is administered through the nose using a specially designed nasal spray applicator.
Each spray delivers 0.5 mg of medication, and the usual recommended dose is four sprays for a single migraine attack.
Migranal works best when used early during a migraine headache. However, it should not be used daily to prevent migraines.
Use Migranal Nasal Spray exactly as prescribed by your healthcare provider. Do not exceed the recommended dose or use it more frequently than directed.
Proper use helps ensure that the medication is delivered into your nostrils correctly.
Before applying Migranal, prepare the nasal spray pump according to the product instructions.
Follow these steps when using Migranal Nasal Spray:
The usual recommended dose for a single migraine attack is 2 mg, delivered as four sprays.
Do not administer more than four sprays for one migraine attack unless your healthcare provider has provided specific instructions consistent with the medication’s safety limits.
Migranal Nasal Spray is intended to treat a migraine attack after it begins.
It is generally recommended to use the medication as soon as you recognize the beginning of a migraine headache.
Some patients experience warning symptoms before a migraine, such as changes in mood, tiredness, or sensitivity to light.
Others experience migraine aura, which may cause temporary visual changes, flashing lights, or tingling sensations.
Migranal is approved to treat migraine headaches with or without aura.
However, it is not specifically intended to eliminate aura symptoms.
Taking migraine medication early during an attack may help reduce headache severity and improve treatment results.
If you wait until the headache becomes more severe, relief may be more difficult to achieve.
Use Migranal according to your healthcare provider’s instructions when a migraine headache begins.
The usual recommended dose of Migranal Nasal Spray is four sprays for one migraine attack.
Each spray contains 0.5 mg of medication.
The first part of the dose consists of one spray into each nostril.
After waiting 15 minutes, administer another spray into each nostril.
This provides a total dose of 2 mg.
The safety of using more than 3 mg within 24 hours or more than 4 mg within seven days has not been established.
These limits are important because excessive dihydroergotamine exposure may cause serious blood vessel narrowing and circulation problems.
Do not take extra sprays simply because your headache has not improved.
Never exceed the recommended daily or weekly dose of Migranal without medical guidance.
Migranal Nasal Spray begins acting after it is absorbed through the nasal passages.
Some patients may begin noticing relief within approximately 30 minutes of treatment.
However, the time needed to experience improvement varies.
Some people may notice that their headache becomes less intense, while others may experience a gradual improvement over the next several hours.
Migranal may also help relieve associated migraine symptoms, such as nausea and sensitivity to light or sound.
The effectiveness of treatment depends on several factors, including the severity of the migraine and how your body responds to the medication.
Migranal does not provide immediate or complete relief for every patient.
Contact your healthcare provider if Migranal does not provide adequate migraine relief instead of increasing your dose on your own.
Yes. You may rest after using Migranal Nasal Spray.
Many people with migraines find that resting in a quiet, dark room helps reduce discomfort during an attack.
Bright lights, loud noises, and physical activity may make migraine symptoms worse.
After administering Migranal, you may lie down comfortably if you prefer.
However, keep your head upright while using the nasal spray to ensure proper medication delivery.
Avoid sniffing deeply or blowing your nose immediately after application.
Resting may help you manage migraine-related symptoms, but it does not replace the medication’s effects.
You do not need to lie down for Migranal to work, although resting in a quiet environment may make you more comfortable during a migraine.
Migranal Nasal Spray is not intended for daily or long-term preventive treatment.
It is designed to treat individual migraine attacks.
Using acute migraine medications too frequently may contribute to medication-overuse headaches.
Medication-overuse headaches occur when repeated use of headache treatments leads to more frequent headaches.
These headaches may become difficult to manage and can interfere with daily activities.
Excessive use of Migranal may also increase the risk of serious side effects, including blood vessel narrowing and reduced circulation.
If you experience frequent migraines, your healthcare provider may recommend preventive treatment.
Preventive migraine medications are taken according to a regular schedule to help reduce the frequency or severity of attacks.
Do not use Migranal daily to prevent migraines or increase your treatment frequency without consulting your healthcare provider.
If your migraine does not improve after using the prescribed dose of Migranal, contact your healthcare provider.
Some migraine attacks may be more difficult to treat than others.
Your healthcare provider may review your symptoms, medication schedule, and response to treatment.
They may recommend another acute migraine medication or a different treatment approach.
Do not repeat Migranal doses beyond the recommended limits.
Avoid combining Migranal with triptans or other ergot-containing migraine medications within 24 hours because these combinations may cause excessive blood vessel narrowing.
If your headache becomes unusually severe or different from your typical migraine, seek medical evaluation.
Seek emergency medical attention if you experience a sudden, extremely severe headache, difficulty speaking, new weakness, chest pain, or unusual changes in vision.
These symptoms may indicate a medical emergency rather than a typical migraine attack.
Migranal Nasal Spray is intended for nasal use only.
Do not inject, swallow, or use the medication through another route.
Use the recommended number of sprays and follow the prescribed treatment schedule.
Migranal can narrow blood vessels and may cause serious circulation problems in susceptible patients.
Tell your healthcare provider if you have heart disease, uncontrolled high blood pressure, circulation problems, or a history of stroke.
Migranal must not be used during pregnancy because it may harm the unborn baby.
It should also be avoided during breastfeeding and for three days after the last dose.
Some medications can cause dangerous interactions with Migranal, including certain antibiotics, antifungal medications, triptans, and other ergot-containing treatments.
Do not use Migranal with strong CYP3A4 inhibitors, such as clarithromycin, ketoconazole, or ritonavir, because these combinations may cause serious circulation problems.
Common side effects may include nasal irritation, nausea, vomiting, dizziness, or an unpleasant taste.
Seek emergency medical attention if you experience chest pain, difficulty breathing, severe numbness, cold or discolored fingers or toes, or other signs of reduced blood circulation.
Use Migranal only for the migraine attacks for which it has been prescribed, and contact your healthcare provider if your symptoms worsen or your treatment becomes less effective.
Migranal Nasal Spray (Dihydroergotamine) is available in the following forms and strength:
Migranal Nasal Spray is a prescription medication used to treat acute migraine attacks with or without aura.
It contains dihydroergotamine mesylate, an active ingredient that helps relieve migraine headache pain by acting on certain serotonin receptors involved in pain signaling and blood vessel regulation.
Migranal belongs to a class of medications called ergot alkaloids. These medications affect blood vessels and nerve pathways involved in migraine attacks.
Although Migranal can help relieve migraine symptoms, it may cause serious side effects in certain patients, especially those with heart disease, circulation problems, or uncontrolled high blood pressure.
Before starting treatment, tell your healthcare provider about any medical conditions, medication allergies, pregnancy, breastfeeding, or other medications you currently use.
Migranal Nasal Spray should not be used by patients with certain heart or blood vessel conditions.
These include coronary artery disease, peripheral vascular disease, and uncontrolled high blood pressure.
Dihydroergotamine can cause blood vessels to narrow, reducing the amount of blood flowing through them.
In people with existing cardiovascular problems, this effect may further reduce blood flow to the heart, brain, or other organs.
Reduced blood flow to the heart may cause chest pain, also called angina.
In severe cases, blood vessel narrowing may contribute to a heart attack or other serious cardiovascular complications.
People with peripheral vascular disease may also experience worsening circulation in their arms or legs.
Symptoms of poor circulation may include cold fingers or toes, numbness, tingling, pain, or changes in skin color.
Tell your healthcare provider if you have heart disease, a history of stroke, or problems with blood circulation.
Seek emergency medical attention if you develop chest pain, difficulty breathing, sudden weakness, or severe circulation problems after using Migranal.
Migranal may cause a significant increase in blood pressure because dihydroergotamine can narrow blood vessels.
Blood pressure is the force of blood pushing against the walls of the arteries.
When blood vessels become narrower, resistance to blood flow increases.
This may cause blood pressure to rise.
People with uncontrolled hypertension are at greater risk of serious complications.
For this reason, Migranal must not be used by patients with uncontrolled high blood pressure.
Tell your healthcare provider if you have hypertension or take medication to control your blood pressure.
Your healthcare provider may assess your cardiovascular health before prescribing Migranal.
Although dizziness or lightheadedness may occur during treatment, these symptoms should not automatically be attributed to low blood pressure.
Seek immediate medical attention if you develop chest pain, a sudden severe headache, or other symptoms suggesting a dangerous increase in blood pressure.
Tell your healthcare provider if you have kidney disease, liver problems, or a history of reduced kidney or liver function.
The liver helps break down dihydroergotamine so the body can process and eliminate it.
The kidneys also contribute to the removal of medication-related substances.
When these organs do not function properly, the body may have difficulty processing or eliminating certain medications.
This can increase exposure to dihydroergotamine and raise the risk of unwanted effects.
Migranal must not be used by patients with severely impaired kidney or liver function.
Patients with less severe kidney or liver problems may require careful medical evaluation before treatment.
Your healthcare provider will consider your medical history and determine whether Migranal is appropriate.
Do not use Migranal if you have severe kidney or liver impairment. Consult your healthcare provider about a safer migraine treatment.
Migranal Nasal Spray can interact with several prescription medications, over-the-counter products, and supplements.
Some medications can increase the amount of dihydroergotamine in the bloodstream.
This may cause excessive blood vessel narrowing and increase the risk of serious circulation problems.
Other medications may have similar effects on blood vessels, making certain combinations unsafe.
For example, Migranal should not be used within 24 hours of taking a triptan medication or another ergot-containing migraine treatment.
Combining these medications may increase the risk of reduced blood flow to important organs.
Tell your healthcare provider about all medications and supplements you currently use.
This includes medications for migraines, infections, high blood pressure, and other medical conditions.
Do not combine Migranal with other migraine medications unless your healthcare provider confirms that the combination and timing are safe.
Migranal must not be combined with medications known as strong CYP3A4 inhibitors.
CYP3A4 is an enzyme that helps the body break down certain medications, including dihydroergotamine.
When this enzyme is strongly blocked, dihydroergotamine may accumulate in the bloodstream.
Higher medication levels can cause excessive narrowing of blood vessels.
This may reduce blood flow to the arms, legs, brain, or other organs.
Examples of medications that may cause this interaction include clarithromycin, erythromycin, ketoconazole, itraconazole, and ritonavir.
Some of these medications are used to treat bacterial, fungal, or viral infections.
Combining them with Migranal may cause serious or life-threatening circulation problems.
Do not use Migranal with strong CYP3A4 inhibitors. Tell your healthcare provider if you are taking antibiotics, antifungal medications, or antiviral treatments.
Migranal may cause side effects such as nausea, vomiting, dizziness, and discomfort inside the nose.
Because Migranal is administered through the nasal passages, some patients may experience local irritation.
This may include a burning sensation, nasal congestion, discomfort, or an unpleasant taste.
Some people may also notice temporary changes in their sense of smell.
Nausea and vomiting can occur as side effects of Migranal, although these symptoms may also be caused by the migraine itself.
Mild symptoms may improve as the effects of the medication wear off.
However, persistent vomiting may lead to dehydration, particularly if you are unable to drink enough fluids.
Dizziness may also affect your ability to perform certain activities safely.
Avoid driving or operating machinery until you know how Migranal affects you.
Contact your healthcare provider if nausea, vomiting, dizziness, or nasal irritation becomes severe or does not improve.
Migranal must not be used during pregnancy because it may cause serious harm to an unborn baby.
Dihydroergotamine can narrow blood vessels and stimulate contractions of the uterus.
The uterus is the muscular organ where a baby develops during pregnancy.
Excessive uterine contractions can increase the risk of pregnancy complications.
Blood vessel narrowing may also reduce blood flow to the developing baby.
These effects may increase the risk of pregnancy loss, premature labor, or other serious complications.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or think you may be pregnant.
Your healthcare provider can recommend another migraine treatment that is more appropriate during pregnancy.
If you become pregnant while using Migranal, stop taking the medication and contact your healthcare provider immediately.
Migranal should not be used while breastfeeding.
Dihydroergotamine may pass into breast milk and expose a nursing infant to the medication.
Ergot alkaloids may cause serious adverse effects in infants.
Possible concerns include vomiting, diarrhea, and changes in blood circulation.
Dihydroergotamine may also interfere with milk production.
For these reasons, breastfeeding is not recommended during Migranal treatment.
Patients should also avoid breastfeeding for at least three days after the last dose.
During this period, breast milk should be expressed and discarded rather than given to the baby.
Your healthcare provider can help determine when breastfeeding may safely resume.
Do not breastfeed while using Migranal or for at least three days after your final dose.
Migranal is designed to treat individual migraine attacks after they begin.
It should not be used as a daily medication to prevent migraines.
Preventive migraine treatments work differently from medications used during an active attack.
They are generally taken regularly to reduce the frequency or severity of future migraines.
Migranal is intended for short-term treatment during an acute migraine episode.
Using it every day or more frequently than recommended may increase the risk of side effects.
Repeated exposure to dihydroergotamine can also increase the risk of blood vessel narrowing and circulation problems.
If you experience frequent migraines, your healthcare provider may recommend a preventive treatment.
Do not use Migranal every day or increase your treatment frequency without consulting your healthcare provider.
Using Migranal too frequently may contribute to medication-overuse headaches.
These headaches are sometimes called rebound headaches.
They can develop when medications intended to relieve acute headaches are used repeatedly over time.
Instead of reducing headache frequency, excessive medication use may cause headaches to become more frequent or persistent.
Some patients may notice that headache symptoms return after the medication’s effects wear off.
Taking additional doses may temporarily relieve symptoms but can contribute to continued headache problems.
The safety of using more than 3 mg of Migranal within 24 hours or more than 4 mg within seven days has not been established.
Your healthcare provider may recommend a different treatment plan if your migraines occur frequently.
Do not exceed your prescribed Migranal dose or use the medication more frequently than recommended.
Do not use Migranal if you have a known allergy to dihydroergotamine, ergot alkaloids, or any other ingredient in the medication.
Before starting treatment, tell your healthcare provider if you have previously experienced an allergic reaction to migraine medications.
Allergic reactions occur when the immune system responds to a substance it mistakenly identifies as harmful.
Possible symptoms include itching, hives, skin rash, redness, or swelling.
Mild reactions may affect only the skin.
However, severe allergic reactions may cause swelling of the face, lips, tongue, or throat.
This swelling can make breathing or swallowing difficult.
A severe allergic reaction may become life-threatening without immediate treatment.
Stop using Migranal and seek emergency medical attention if you develop difficulty breathing or swelling of the tongue or throat.
Contact your healthcare provider if your migraine symptoms become worse or Migranal does not provide adequate relief.
You should also seek medical advice if you experience persistent nausea, vomiting, dizziness, or nasal irritation.
Report any unusual numbness, tingling, coldness, or changes in skin color affecting your fingers or toes.
These symptoms may indicate reduced blood circulation and require prompt evaluation.
Tell your healthcare provider if your migraine attacks become more frequent or you regularly need additional medication for relief.
Your healthcare provider may recommend another acute migraine treatment or a preventive medication.
Seek emergency medical attention if you develop chest pain, difficulty breathing, sudden weakness, severe circulation problems, or signs of a serious allergic reaction.
Continue using Migranal only for prescribed migraine attacks and follow the recommended daily and weekly dosing limits.
Yes. Migranal Nasal Spray may be used to treat menstrual migraines, which are migraine attacks that occur around the time of menstruation. These migraines are often triggered by changes in estrogen levels before or during a menstrual period. Migranal helps relieve migraine headache pain and associated symptoms, such as nausea and sensitivity to light and sound. However, it is intended to treat migraine attacks after they begin, not to prevent menstrual migraines. Consult your healthcare provider about the appropriate dosage and timing of Migranal treatment, especially if you experience frequent or severe menstrual migraines.
The usual recommended dose of Migranal Nasal Spray is one spray in each nostril, followed by another spray in each nostril after 15 minutes. This provides a total of four sprays, equivalent to 2 mg, for one migraine attack. The safety of using more than 3 mg within 24 hours or more than 4 mg within seven days has not been established. Migranal should not be used daily or more frequently than prescribed because excessive use may increase the risk of serious circulation problems and medication-overuse headaches. Follow your healthcare provider’s instructions and do not take extra doses if your migraine does not improve.
Migranal Nasal Spray may be used with certain other migraine medications when recommended by your healthcare provider. However, some combinations can cause dangerous interactions. For example, do not use Migranal within 24 hours of taking a triptan or another ergot-containing migraine medication. Combining these medications may cause excessive blood vessel narrowing and reduce blood flow to important organs. Migranal may also interact with certain antibiotics, antifungal medications, and antiviral treatments. Tell your healthcare provider about all medications and supplements you currently use before starting treatment.
Migranal Nasal Spray is not generally considered addictive in the same way as opioids or other medications that can cause substance dependence. However, using it too frequently may lead to medication-overuse headaches and other serious complications. Some patients may begin relying on repeated doses when migraines occur frequently, which can make their headaches more difficult to manage. Use Migranal only for prescribed migraine attacks and do not exceed the recommended dosage or frequency. If you find yourself needing Migranal frequently, contact your healthcare provider to discuss preventive migraine treatment.
Yes. Using Migranal Nasal Spray too frequently may contribute to rebound headaches, medically known as medication-overuse headaches. These headaches occur when medications used to treat acute migraine attacks are taken too often over an extended period. Instead of providing lasting relief, frequent medication use may cause headaches to become more persistent or occur more often. To reduce this risk, follow your prescribed dosing schedule and avoid using Migranal as a daily migraine treatment. Contact your healthcare provider if your headaches become more frequent or you regularly need additional medication for relief. Your healthcare provider may recommend a preventive treatment to help reduce future migraine attacks.
| Generic name: | Dihydroergotamine |
|---|---|
| Formulation: | Nasal spray ampule |
| Strength(s): | 4mg/mL |
| Quantities Available: | 6mL, 18mL |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Migranal Nasal Spray (dihydroergotamine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Migranal Nasal Spray is commonly prescribed in dosages of 1 spray (0.5 mg) into each nostril, up to 2 sprays (1 mg) per nostril per day. For a 90-day supply, assuming a maximum usage of 4 sprays per day, you would order up to 360 sprays (90 days x 4 sprays per day).
No, we do not sell dihydroergotamine directly on our website. However, you can still enjoy low prices on Migranal Nasal Spray, which contains dihydroergotamine as an active ingredient. To purchase Migranal Nasal Spray, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Migranal Nasal Spray (dihydroergotamine) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Migranal Nasal Spray (Dihydroergotamine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Migranal Nasal Spray (Dihydroergotamine).
REVIEWS